Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Childhood rhabdomyosarcoma.

David Rodeberg1, Charles Paidas

  • 1Department of Pediatric Surgery, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Seminars in Pediatric Surgery
|February 7, 2006
PubMed
Summary

Rhabdomyosarcoma (RMS) is a childhood striated muscle tumor. Multimodality therapy has improved survival to over 70%, with prognosis depending on various clinical and biological factors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Too Many Cooks in the Kitchen or an Organized Brigade? A Success Story of Collaboration Between Pediatric Urology and Surgery to Treat Children With Renal Tumors.

Journal of pediatric surgery·2025
Same author

ASO Visual Abstract: Essential Knowledge and Skills for the Practice of Pediatric Surgical Oncology: a Modified Delphi Consensus Study by the APSA Cancer Committee.

Annals of surgical oncology·2025
Same author

The International Soft Tissue Sarcoma Consortium: The baseline analysis of rhabdomyosarcoma data.

Cancer·2025
Same author

ASO Author Reflections: Cancer Surgery in Infants and Children: Developing an International Consensus.

Annals of surgical oncology·2025
Same author

Essential Knowledge and Skills for the Practice of Pediatric Surgical Oncology: A Modified Delphi Consensus Study by the APSA Cancer Committee.

Annals of surgical oncology·2025
Same author

Lymph Node Staging and Treatment in Pediatric Patients With Soft Tissue Sarcomas: A Consensus Opinion From the Children's Oncology Group, European paediatric Soft Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe.

Pediatric blood & cancer·2025

Area of Science:

  • Pediatric Oncology
  • Surgical Oncology
  • Molecular Biology

Background:

  • Rhabdomyosarcoma (RMS) is a malignant tumor originating from striated muscle, primarily affecting children.
  • Significant advancements in multimodality therapy have led to a greater than 70% 5-year survival rate for RMS.
  • Prognosis is influenced by primary tumor site, patient age, resection completeness, metastatic status, histology, and tumor biology.

Purpose of the Study:

  • To outline the critical role of pretreatment staging and postoperative clinical grouping in risk stratification for Rhabdomyosarcoma.
  • To emphasize the importance of surgical resection in improving survival outcomes for pediatric RMS patients.
  • To highlight the current treatment standards based on Children's Oncology Group protocols.

Main Methods:

  • Review of multimodality treatment protocols for Rhabdomyosarcoma.
  • Analysis of prognostic factors including tumor site, age, resection status, and metastatic burden.
  • Assessment of risk stratification strategies based on pretreatment stage and postoperative clinical grouping.

Main Results:

  • Multimodality therapy has achieved over 70% 5-year survival for Rhabdomyosarcoma.
  • Pretreatment staging (site, size, nodes, metastasis) is vital for treatment planning.
  • Postoperative clinical grouping, assessing resection completeness, significantly impacts survival.

Conclusions:

  • Complete surgical resection of Rhabdomyosarcoma, including microscopic disease, improves survival.
  • Surgeons play a crucial role in risk stratification and local tumor control.
  • Current Rhabdomyosarcoma treatment follows established protocols from the Children's Oncology Group.

Related Experiment Videos